U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period ...

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were ...

Mature overall survival results of the INAVO120 trial were presented in a press conference for the American Society of ...

Second, Pfizer's forward dividend yield stands at 7.47%. At first glance, the drugmaker's dividend payout ratio of 122.5% ...

The tariff war the U.S. is waging against most of the world stabilized somewhat earlier this month. But let's face facts -- ...

Last month, an average of about 350 people died each week from COVID, according to data from the CDC. With available vaccines and treatments, why are people still dying?

The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

Pfizer's (NYSE: PFE) management team is confident in its 2025 opportunities. Where to invest $1,000 right now? Our analyst ...

Pfizer is paying $1.25 billion to join the PD-(L1)xVEGF bispecific race. | Pfizer is paying $1.25 billion to join the ...

Astellas Pharma (ALPMY) and Pfizer (PFE) announced longer-term follow-up results from an open-label extension of the Phase 3 ...

Gerard O’Donnell, a high performance athletics coach, specialising in sprints and hurdles, is helping the country's sprint ...